欧洲乳腺癌专家学会/晚期乳腺癌全球联盟转移性乳腺癌诊疗质量指标
欧洲乳腺癌专家学会与晚期乳腺癌全球联盟联合制定首套转移性乳腺癌专用质量指标(QI)。多学科欧洲专家组逐条讨论每项QI的定义、乳腺中心应达到的最低与目标标准及选择理由,证据级别按美国医疗保健研究与质量局分类简版确定。共识形成覆盖多学科与支持治疗的可及性和参与、疾病病理特征恰当评估、全身治疗及放疗的QI。
要点
- 首套专门针对转移性乳腺癌、应常规测量与评价的质量指标。
- 每项QI均给出定义、乳腺中心应达到的最低与目标标准及选择理由。
- QI覆盖多学科与支持治疗可及性、病理特征评估、全身治疗及放疗。
核心结论
- 该多步骤项目旨在使转移性乳腺癌质量指标被常规测量与评价,以确保乳腺癌中心在转移性疾病患者诊疗中达到规定标准。
研究设计与样本
- 欧洲乳腺癌专家学会与晚期乳腺癌全球联盟合作,由欧洲乳腺癌多学科专家组召开会议逐条讨论已识别的每项质量指标,证据级别按美国医疗保健研究与质量局分类简版确定。
主要发现
- 经工作组共识制定了用于测量多学科与支持治疗的可及性和参与、疾病病理特征的恰当评估、全身治疗及放疗的质量指标。
关键数值与推荐
- 每项质量指标均报告定义、乳腺中心应达到的最低与目标标准以及选择理由,证据级别按美国医疗保健研究与质量局分类简版确定。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Improvement in the care of patients with metastatic breast cancer (MBC) can only occur if the adequate quality of care is implemented and verified, including access to multidisciplinary, specialised care given in accordance with high-quality guidelines. To this purpose, European Society of Breast Cancer Specialists and the Advanced Breast Cancer Global Alliance joined efforts to develop the first set of quality indicators (QI) specifically for MBC that should be routinely measured and evaluated to ensure that breast cancer centres meet the required standards. METHODS: A working group of multidisciplinary European experts in breast cancer met to discuss each identified QI, reporting the definition, the minimum and target standard for breast cancer centres to achieve, and the motivation for selection. The level of evidence was determined according to the short version of the United States Agency for Healthcare Research and Quality classification. RESULTS: QI to measure access to and involvement in multidisciplinary and supportive care, appropriate pathological characterisation of disease, systemic therapies and radiotherapy were developed with the consensus of the working group. CONCLUSIONS: This is the first effort of a multistep project that aims to have QI for MBC routinely measured and evaluated to ensure that breast cancer centres achieve mandated standards in the care of patients with metastatic disease.
引用
- Cardoso F, McCartney A, Ponti A, et al. European Society of Breast Cancer Specialists/Advanced Breast Cancer Global Alliance quality indicators for metastatic breast cancer care. Eur J Cancer. 2023. PMID: 37146504. doi:10.1016/j.ejca.2023.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。